This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA) (UNMASK)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2013 by ApniCure, Inc..
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
ApniCure, Inc. Identifier:
First received: September 7, 2012
Last updated: September 3, 2013
Last verified: September 2013
The objective of the Study is to observe the use and utility of the Winx Sleep Therapy System in a clinical practice, for the treatment of patients with obstructive sleep apnea (OSA).

Obstructive Sleep Apnea

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA)

Resource links provided by NLM:

Further study details as provided by ApniCure, Inc.:

Estimated Enrollment: 1000
Study Start Date: September 2012
Estimated Study Completion Date: February 2014
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Subjects with obstructive sleep apnea (OSA)

Exclusion Criteria

  • Has a severe respiratory disorder, such as severe lung disease, pneumothorax, etc.
  • Has loose teeth or advanced periodontal disease.
  • Is under the age of 18.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01683721

Contact: Lawrence Siegel, MD 650-361-9399

United States, Florida
St. Petersburg Sleep Disorders Center Recruiting
St. Petersburg, Florida, United States, 33707
Contact    727-360-0853      
Principal Investigator: Neil T Feldman, MD         
United States, Texas
Sleep Medicine Associates of Texas (SMAT) Recruiting
Dallas, Texas, United States, 75231
Contact: Philip Becker, MD    214-389-1740      
Principal Investigator: Philip Becker, MD         
Sponsors and Collaborators
ApniCure, Inc.
  More Information

Responsible Party: ApniCure, Inc. Identifier: NCT01683721     History of Changes
Other Study ID Numbers: 12023
Study First Received: September 7, 2012
Last Updated: September 3, 2013

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases processed this record on June 23, 2017